Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients
Clinical trial NCT00461617 · COMPLETED
Trial details
- NCT number
- NCT00461617
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2007-07-01
- Enrollment
- 291
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.